Our Company was originally incorporated as ÂSai ParenteralÂs Private LimitedÂ, a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 12, 2001, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, our Company was converted into a public limited company pursuant to resolution of our Board dated December 24, 2021 and a special resolution of our Shareholders dated January 05, 2022, and consequently, the name of our Company was changed to ÂSai ParenteralÂs Limited and a fresh certificate of incorporation consequent upon conversion to public limited company dated January 17, 2022, was issued to our Company by the RoC. Major Events and Milestones: 2001 - Company was incorporated as a Private Limited Company under the name of Sai ParenteralÂs Private Limited. 2016 - Change in the ownership of the Company, due to acquisition of Equity Shares by our Promoters from the erstwhile promoters of the Company. - Acquired Unit-I and Unit-II. 2021 - Launch of Prefilled technology equipment in Unit-I. 2022 - Acquired Unit III and related business from Reichindia Pharma Limited. For details see ÂAcquisition of Business undertaking of Reichindia Pharma Limited on a slump sale basis on page 270. - Acquired Unit IV and related business from Medreich Limited. For details see ÂAcquisition of Business undertaking of Medreich Limited on a slump sale basis on page 271. 2023 - Incorporated, SP Analytics Private Limited one of our Subsidiary - Our Company achieved a turnover of ? 1,000 million 2024 - Our Company acquired 100 % shareholding of Revat Laboratories Private Limited, pursuant to which it became a wholly owned subsidiary of our Company. 2025 - Incorporated a wholly owned subsidiary, Sai Parenterals Pte. Limited in Singapore. - Acquisition of foreign step-down subsidiaries, Noumed Pharmaceuticals Pty Limited in Australia and Noumed Pharmaceuticals Limited in New Zealand. |
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article